<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36763225</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Analysis of microRNA-199a-3p expression in CD4<sup>+</sup> T cells of systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1683</StartPage><EndPage>1694</EndPage><MedlinePgn>1683-1694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06534-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Accumulating evidence have suggested microRNAs (miRNAs) play important roles in the pathogenesis of systemic lupus erythematosus (SLE). Here we aimed to explore aberrant expression of miRNAs in CD4<sup>+</sup> T cells from SLE patients and their potential function in SLE pathogenesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">First, next-generation sequencing was performed on CD4<sup>+</sup> T cells from four SLE patients and three healthy controls (HCs). Candidate miRNAs were then validated in CD4<sup>+</sup> T cells from 97 patients with SLE, 16 patients with rheumatoid&#xa0;arthritis, and 12 HCs using qRT-PCR. Then the relationship between the candidate miRNA and clinical characteristics was analyzed. Bioinformatics analysis and validation of the target genes of the candidate miRNA were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 66 upregulated miRNAs and 70 downregulated miRNAs were found between SLE and normal CD4<sup>+</sup> T cells samples. miR-199a-3p was identified significant upregulation in the CD4<sup>+</sup> T cells of lupus patients. High expression of miR-199a-3p was correlated with several clinical characteristics including low C3 level, positive anti-dsDNA antibody, high ESR level, active lupus nephritis, and active disease activity. When distinguishing active LN from non-LN or active lupus from stable lupus, the AUCs of miR-199a-3p were 0.68 and 0.70, respectively. And the expression of miR-199a-3p, involved in JAK-STAT signaling pathway, was negatively correlated with the STAM expression in CD4<sup>+</sup> T cells of SLE.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggested a novel and promising role of miR-199a-3p in CD4<sup>+</sup> T cells for SLE. Further studies are needed to precisely determine the function of miR-199a-3p in this disease. Key Points &#x2022; Aberrant expression of miRNAs in CD4<sup>+</sup> T cells and their potential function in SLE pathogenesis remained unclear. &#x2022; miR-199a-3p in CD4+ T cells plays a novel role in the pathogenesis of SLE and serves as a potential target for SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Huijing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Institute of Nephrology, Zhejiang University, Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Geng</LastName><ForeName>Guannan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Editing Core Facility, Center for Excellence in Brain Science and intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Danting</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Institute of Nephrology, Zhejiang University, Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5257-5768</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. ye_shuang2000@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SHDC2020CR1015B</GrantID><Agency>Clinical Research Plan of SHDC</Agency><Country/></Grant><Grant><GrantID>2016PWGZR05</GrantID><Agency>Cultivating Funds of Renji Hospital South Campus</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">CD4+ T cells</Keyword><Keyword MajorTopicYN="N">JAK-STAT signaling pathway</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36763225</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06534-7</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06534-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110&#x2013;2121. https://doi.org/10.1056/NEJMra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Doria A, Gatto M, Zen M, Iaccarino L, Punzi L (2014) Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 13(7):770&#x2013;777. https://doi.org/10.1016/j.autrev.2014.01.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.01.055</ArticleId><ArticleId IdType="pubmed">24480071</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC (2017) Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med 23(7):615&#x2013;635. https://doi.org/10.1016/j.molmed.2017.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2017.05.006</ArticleId><ArticleId IdType="pubmed">28623084</ArticleId><ArticleId IdType="pmc">5650102</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L (2017) Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol 13(5):280&#x2013;290. https://doi.org/10.1038/nrrheum.2017.43</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2017.43</ArticleId><ArticleId IdType="pubmed">28360423</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng X, Brown J, Choi SC, Li W, Morel L (2020) Metabolic determinants of lupus pathogenesis. Immunol Rev 295(1):167&#x2013;186. https://doi.org/10.1111/imr.12847</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12847</ArticleId><ArticleId IdType="pubmed">32162304</ArticleId><ArticleId IdType="pmc">7180129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP, Sobel ES, Brusko TM, Morel L (2015) Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med 7(274):274ra218. https://doi.org/10.1126/scitranslmed.aaa0835</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa0835</ArticleId></ArticleIdList></Reference><Reference><Citation>Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM (2011) IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. J Immunol 186(8):4862&#x2013;4871. https://doi.org/10.4049/jimmunol.1003777</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003777</ArticleId><ArticleId IdType="pubmed">21389253</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Tsokos GC (2015) T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest 125(6):2220&#x2013;2227. https://doi.org/10.1172/jci78087</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci78087</ArticleId><ArticleId IdType="pubmed">25961450</ArticleId><ArticleId IdType="pmc">4497749</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Chang C, Lu Q (2017) Epigenetics of CD4+ T cells in autoimmune diseases. Curr Opin Rheumatol 29(4):361&#x2013;368. https://doi.org/10.1097/bor.0000000000000393</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000393</ArticleId><ArticleId IdType="pubmed">28362657</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng G, Wang H, Xin W, Liu Z, Chen J, Danting Z, Han F, Ye S (2021) tRNA derived fragment (tRF)-3009 participates in modulation of IFN-&#x3b1;-induced CD4(+) T cell oxidative phosphorylation in lupus patients. J Transl Med 19(1):305. https://doi.org/10.1186/s12967-021-02967-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02967-3</ArticleId><ArticleId IdType="pubmed">34256772</ArticleId><ArticleId IdType="pmc">8278670</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31(1):37&#x2013;49. https://doi.org/10.1093/carcin/bgp272</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgp272</ArticleId><ArticleId IdType="pubmed">19955394</ArticleId></ArticleIdList></Reference><Reference><Citation>Stypinska B, Paradowska-Gorycka A (2015) Cytokines and MicroRNAs as candidate biomarkers for systemic lupus erythematosus. Int J Mole Sci 16(10):24194&#x2013;24218. https://doi.org/10.3390/ijms161024194</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms161024194</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, Bengtsson AA, Heegaard NH (2013) Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65(5):1324&#x2013;1334. https://doi.org/10.1002/art.37890</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37890</ArticleId><ArticleId IdType="pubmed">23401079</ArticleId><ArticleId IdType="pmc">6662589</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Jiang L, Wang B, Hu Q, Deng S, Huang J, Sun X, Zhang Y, Feng L, Chen W (2022) Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p. Clin Biochem 107:55&#x2013;61. https://doi.org/10.1016/j.clinbiochem.2022.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2022.05.004</ArticleId><ArticleId IdType="pubmed">35598633</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RP, Hahn BH, Bischoff DS (2022) Identification and contribution of inflammation-induced novel MicroRNA in the pathogenesis of systemic lupus erythematosus. Front Immunol 13:848149. https://doi.org/10.3389/fimmu.2022.848149</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848149</ArticleId><ArticleId IdType="pubmed">35444657</ArticleId><ArticleId IdType="pmc">9013931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heijde D, Aletaha D, Carmona L, Edwards CJ, Kvien TK, Kouloumas M, Machado P, Oliver S, de Wit M, Dougados M (2015) 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis 74(1):8&#x2013;13. https://doi.org/10.1136/annrheumdis-2014-206350</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2014-206350</ArticleId><ArticleId IdType="pubmed">25261577</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman DD, Iba&#xf1;ez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288&#x2013;291</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, S&#xe1;nchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677&#x2013;2686. https://doi.org/10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId><ArticleId IdType="pmc">3409311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. Rna 10(10):1507&#x2013;1517. https://doi.org/10.1261/rna.5248604</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5248604</ArticleId><ArticleId IdType="pubmed">15383676</ArticleId><ArticleId IdType="pmc">1370637</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, Wang H, Shi X, Ye L, Wu K, Lin K, Ye S, Li B, Zhang H, Lin Q, Ye S, Xue X, Chen C (2018) NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker. J Transl Med 16(1):370. https://doi.org/10.1186/s12967-018-1739-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1739-5</ArticleId><ArticleId IdType="pubmed">30577810</ArticleId><ArticleId IdType="pmc">6303892</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Ye L, Chen X, Zhang H, Zhou Y, Ding X, Chen D, Lin Q, Chen C (2019) MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) Polymerase-1 in patients with systemic lupus erythematosus. Chem Biol Interact 306:110&#x2013;116. https://doi.org/10.1016/j.cbi.2019.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2019.04.015</ArticleId><ArticleId IdType="pubmed">30991045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye H, Su B, Ni H, Li L, Chen X, You X, Zhang H (2018) microRNA-199a may be involved in the pathogenesis of lupus nephritis via modulating the activation of NF-&#x3ba;B by targeting Klotho. Mol Immunol 103:235&#x2013;242. https://doi.org/10.1016/j.molimm.2018.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2018.10.003</ArticleId><ArticleId IdType="pubmed">30316188</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong A, Wang J, Mao XL, Jiang Y, Fan Y (2019) MiR-199a-3p modulates the function of dendritic cells involved in transplantation tolerance by targeting CD86. Hla 94(6):493&#x2013;503. https://doi.org/10.1111/tan.13677</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.13677</ArticleId><ArticleId IdType="pubmed">31448543</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A, Padjen I, Fanouriakis A, Boumpas DT (2019) Pathogenic and therapeutic relevance of JAK/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent. Cells 8(8).&#xa0; https://doi.org/10.3390/cells8080898</Citation></Reference><Reference><Citation>Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C (2019) Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Phytomedicine 62:152965. https://doi.org/10.1016/j.phymed.2019.152965</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.152965</ArticleId><ArticleId IdType="pubmed">31129432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zan H, Tat C, Casali P (2014) MicroRNAs in lupus. Autoimmunity 47(4):272&#x2013;285. https://doi.org/10.3109/08916934.2014.915955</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2014.915955</ArticleId><ArticleId IdType="pubmed">24826805</ArticleId><ArticleId IdType="pmc">4239026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao B, Xiang W, Li X, He C, Chen L, Xia X, Peng T, Peng L, Yang X, Zhong C (2021) Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus. Inflamm Res 70(3):285&#x2013;296. https://doi.org/10.1007/s00011-020-01433-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01433-y</ArticleId><ArticleId IdType="pubmed">33507312</ArticleId></ArticleIdList></Reference><Reference><Citation>Karantanos T, Christofides A, Bardhan K, Li L, Boussiotis VA (2016) Corrigendum: regulation of T cell differentiation and function by EZH2. Front Immunol 7:346. https://doi.org/10.3389/fimmu.2016.00346</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00346</ArticleId><ArticleId IdType="pubmed">27648006</ArticleId><ArticleId IdType="pmc">5022364</ArticleId></ArticleIdList></Reference><Reference><Citation>You H, Xu D, Zhao J, Li J, Wang Q, Tian X, Li M, Zeng X (2020) JAK inhibitors: prospects in connective tissue diseases. Clin Rev Allergy Immunol 59(3):334&#x2013;351. https://doi.org/10.1007/s12016-020-08786-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08786-6</ArticleId><ArticleId IdType="pubmed">32222877</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM (2017) JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77(5):521&#x2013;546. https://doi.org/10.1007/s40265-017-0701-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-017-0701-9</ArticleId><ArticleId IdType="pubmed">28255960</ArticleId><ArticleId IdType="pmc">7102286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu H, Kim J, Kim D, Lee JE, Chung Y (2019) Cellular and molecular links between autoimmunity and lipid metabolism. Mol Cells 42(11):747&#x2013;754. https://doi.org/10.14348/molcells.2019.0196</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2019.0196</ArticleId><ArticleId IdType="pubmed">31766832</ArticleId><ArticleId IdType="pmc">6883973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesilaty-Gross S, Reich A, Motro B, Wides R (1999) The Drosophila STAM gene homolog is in a tight gene cluster, and its expression correlates to that of the adjacent gene ial. Gene 231(1&#x2013;2):173&#x2013;186. https://doi.org/10.1016/s0378-1119(99)00053-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0378-1119(99)00053-0</ArticleId><ArticleId IdType="pubmed">10231582</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Itoh T, Arai K (1996) JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J Biol Chem 271(21):12681&#x2013;12686. https://doi.org/10.1074/jbc.271.21.12681</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.21.12681</ArticleId><ArticleId IdType="pubmed">8647882</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16(12):939&#x2013;946. https://doi.org/10.1177/0961203307084158</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307084158</ArticleId><ArticleId IdType="pubmed">18042587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadiri N, Emamnia N, Ganjalikhani-Hakemi M, Ghaedi K, Etemadifar M, Salehi M, Shirzad H, Nasr-Esfahani MH (2018) Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients. Gene 659:109&#x2013;117. https://doi.org/10.1016/j.gene.2018.03.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.03.035</ArticleId><ArticleId IdType="pubmed">29551498</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G (2008) Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27(34):4712&#x2013;4723. https://doi.org/10.1038/onc.2008.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2008.112</ArticleId><ArticleId IdType="pubmed">18408758</ArticleId><ArticleId IdType="pmc">3041589</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>